title: Subcutaneous clodronate: a study evaluating efficacy in hypercalcemia of malignancy and local toxicity.
abstract: The logistics of administering intravenous bisphosphonates may be problematic in the care of advanced cancer patients, especially in the home setting. Hypodermoclysis is a convenient method of administering fluid via subcutaneous infusion, presently used in the domiciliary setting. Results of the administration of clodronate via this route are reported.
authors.affiliation: Palliative Care Program, Grey Nuns Community Hospital & Health Centre, Cross Cancer Institute, Edmonton, Canada.
authors.forename: P
authors.initials: P
authors.lastname: Walker
authors.forename: S
authors.initials: S
authors.lastname: Watanabe
authors.forename: P
authors.initials: P
authors.lastname: Lawlor
authors.forename: J
authors.initials: J
authors.lastname: Hanson
authors.forename: J
authors.initials: J
authors.lastname: Pereira
authors.forename: E
authors.initials: E
authors.lastname: Bruera
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D004002:Clodronic Acid / Q000008:administration & dosage* / Q000009:adverse effects; D005260:Female; D006801:Humans; D006934:Hypercalcemia / Q000188:drug therapy*; D007279:Injections, Subcutaneous; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000150:complications*
chemical_list: D004002:Clodronic Acid